Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
academic, addressing, alternative, area, beginning, belief, broader, build, building, capacity, category, comparison, compete, confer, core, delivery, diversify, drop, ease, effort, enrollment, extensive, geopolitical, group, half, improvement, inadequate, introduce, IOP, larger, monetize, NCE, neuroprotection, optimization, outlook, outsource, oversee, partnership, patient, pressure, promise, provisional, ready, recoverability, recoverable, requisite, respond, retaining, robust, ROU, sell, speed, storage, stream, sum, superior, symptomology, therapy, toxicology, undiscounted
Removed:
Acquiring, adding, biopharmaceutical, Bringing, CDMO, commencement, commercializing, contingent, criteria, declared, discipline, field, filed, function, hire, integrate, integrating, integrative, lack, medicine, obtaining, outbreak, protecting, Registration, researching, strict, synthesizing, treated, utilizing, World
Filing tables
Filing exhibits
INM similar filings
Filing view
External links
Exhibit 32.2
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Brenda Edwards, the Chief Financial Officer of InMed Pharmaceuticals Inc. (the “Company”), hereby certify that, to my knowledge:
1. | The Quarterly Report on Form 10-Q for the quarter ended September 30, 2022 (the “Report”) of the Company fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: November 14, 2022
/s/ Brenda Edwards | ||
Name: | Brenda Edwards | |
Title: | Interim Chief Financial Officer |